Skip to content

Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension

Hemodynamic Effects of Acute Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension: Single-center Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04697875
Acronym
HEXA
Enrollment
24
Registered
2021-01-06
Start date
2021-02-01
Completion date
2023-05-31
Last updated
2023-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Pulmonary

Keywords

hypoxia, exercise, hemodynamics

Brief summary

To study hemodynamic effects of acute normobaric hypoxia during exercise in patients with pulmonary hypertension in a single-center randomized controlled trial.

Interventions

Inhalation of deoxygenated air through an altitude simulator (Altitrainer), for approx. 1/2 hour given by a facemask, first at rest and then during exercise.

Inhalation of room air through an altitude simulator (Altitrainer), for approx. 1/2 hour given by a facemask, first at rest and then during exercise.

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent as documented by signature (Appendix Informed Consent Form) * PH class I (PAH) or IV (CTEPH) diagnosed according to guidelines: mean pulmonary artery pressure \>20 mmHg, pulmonary vascular resistance ≥3 wood units, pulmonary arterial wedge pressure ≤15 mmHg during baseline measures at the diagnostic right-heart catheterization

Exclusion criteria

* resting partial pressure of oxygen \<8 kilopascal at Zürich altitude on ambient air * exposure to an altitude \>1000 m for ≥3 nights during the last 2 weeks before the study * inability to follow the procedures of the study * patients who take nitrates * other clinically significant concomitant end-stage disease (e.g., renal failure, hepatic dysfunction)

Design outcomes

Primary

MeasureTime frameDescription
mean pulmonary artery pressure (mPAP) / cardiac output (CO)2 hoursDifference in mPAP/CO during exercise between tests under hypoxia vs. normoxia

Secondary

MeasureTime frameDescription
Differences in pulmonary arterial pressure2 hoursDifferences in pulmonary arterial pressure at rest and during exercise, with normoxia/hypoxia
Differences in cardiac output2 hoursDifferences in cardiac output at rest and during exercise, with normoxia/hypoxia
Pulmonary vascular resistance2 hoursDifferences in pulmonary vascular resistance at rest and during exercise, with normoxia/hypoxia
Differences in pulmonary artery wedge pressure2 hoursDifferences in pulmonary artery wedge pressure at rest and during exercise, with normoxia/hypoxia
Differences in right atrial pressure2 hoursDifferences in right atrial pressure at rest and during exercise, with normoxia/hypoxia
Differences in mixed venous oxygen saturation2 hoursDifferences in mixed venous oxygen saturation at rest and during exercise, with normoxia/hypoxia
Differences in blood pressure2 hoursDifferences in blood pressure at rest and during exercise, with normoxia/hypoxia
Differences in heart rate2 hoursDifferences in heart rate at rest and during exercise, with normoxia/hypoxia
Differences in arterial blood gases2 hoursDifferences in arterial blood gases at rest and during exercise, with normoxia/hypoxia
Differences in mixed venous blood gases2 hoursDifferences in mixed venous blood gases at rest and during exercise, with normoxia/hypoxia
Differences in cerebral tissue oxygenation2 hoursDifferences in cerebral tissue oxygenation at rest and during exercise, with normoxia/hypoxia
Differences in muscle tissue oxygenation2 hoursDifferences in muscle tissue oxygenation at rest and during exercise, with normoxia/hypoxia
Differences in symptoms (Borg dyspnoea)2 hoursDifferences in symptoms (Borg dyspnoea) at rest and during exercise, with normoxia/hypoxia
Differences in symptoms (Borg leg effort)2 hoursDifferences in symptoms (Borg leg effort) at rest and during exercise, with normoxia/hypoxia
Differences in oxygen saturation2 hoursDifferences in oxygen saturation at rest and during exercise, with normoxia/hypoxia

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026